281 related articles for article (PubMed ID: 28512147)
1. Nrf2 inactivation enhances placental angiogenesis in a preeclampsia mouse model and improves maternal and fetal outcomes.
Nezu M; Souma T; Yu L; Sekine H; Takahashi N; Wei AZ; Ito S; Fukamizu A; Zsengeller ZK; Nakamura T; Hozawa A; Karumanchi SA; Suzuki N; Yamamoto M
Sci Signal; 2017 May; 10(479):. PubMed ID: 28512147
[TBL] [Abstract][Full Text] [Related]
2. Divergent Regulation of Decidual Oxidative-Stress Response by NRF2 and KEAP1 in Preeclampsia with and without Fetal Growth Restriction.
Mundal SB; Rakner JJ; Silva GB; Gierman LM; Austdal M; Basnet P; Elschot M; Bakke SS; Ostrop J; Thomsen LCV; Moses EK; Acharya G; Bjørge L; Iversen AC
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216082
[TBL] [Abstract][Full Text] [Related]
3. Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia.
Hoffmann DS; Weydert CJ; Lazartigues E; Kutschke WJ; Kienzle MF; Leach JE; Sharma JA; Sharma RV; Davisson RL
Hypertension; 2008 Apr; 51(4):1058-65. PubMed ID: 18259014
[TBL] [Abstract][Full Text] [Related]
4. Decreased lectin-like oxidized LDL receptor 1 (LOX-1) and low Nrf2 activation in placenta are involved in preeclampsia.
Chigusa Y; Tatsumi K; Kondoh E; Fujita K; Nishimura F; Mogami H; Konishi I
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1862-70. PubMed ID: 22791762
[TBL] [Abstract][Full Text] [Related]
5. The effects of Nrf2 deletion on placental morphology and exchange capacity in the mouse.
Kweider N; Huppertz B; Rath W; Lambertz J; Caspers R; ElMoursi M; Pecks U; Kadyrov M; Fragoulis A; Pufe T; Wruck CJ
J Matern Fetal Neonatal Med; 2017 Sep; 30(17):2068-2073. PubMed ID: 27633272
[TBL] [Abstract][Full Text] [Related]
6. Molecular hydrogen ameliorates several characteristics of preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model.
Ushida T; Kotani T; Tsuda H; Imai K; Nakano T; Hirako S; Ito Y; Li H; Mano Y; Wang J; Miki R; Yamamoto E; Iwase A; Bando YK; Hirayama M; Ohno K; Toyokuni S; Kikkawa F
Free Radic Biol Med; 2016 Dec; 101():524-533. PubMed ID: 27789293
[TBL] [Abstract][Full Text] [Related]
7. Role of a fetal defence mechanism against oxidative stress in the aetiology of preeclampsia.
Wruck CJ; Huppertz B; Bose P; Brandenburg LO; Pufe T; Kadyrov M
Histopathology; 2009 Jul; 55(1):102-6. PubMed ID: 19614772
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in the placenta: the role of reactive oxygen species signaling.
Pereira RD; De Long NE; Wang RC; Yazdi FT; Holloway AC; Raha S
Biomed Res Int; 2015; 2015():814543. PubMed ID: 25705690
[TBL] [Abstract][Full Text] [Related]
9. Pregnant alpha-1-microglobulin (A1M) knockout mice exhibit features of kidney and placental damage, hemodynamic changes and intrauterine growth restriction.
Aleksenko L; Åkerström B; Hansson E; Erlandsson L; Hansson SR
Sci Rep; 2020 Nov; 10(1):20625. PubMed ID: 33244052
[TBL] [Abstract][Full Text] [Related]
10. Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: implications for atherosclerosis and preeclampsia.
Mann GE; Niehueser-Saran J; Watson A; Gao L; Ishii T; de Winter P; Siow RC
Sheng Li Xue Bao; 2007 Apr; 59(2):117-27. PubMed ID: 17437032
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-Mediated Simultaneous Downregulation of Placental Nrf2 and sFlt1 Improves Maternal and Fetal Outcomes in a Preeclampsia Mouse Model.
Li L; Li H; Xue J; Chen P; Zhou Q; Zhang C
ACS Biomater Sci Eng; 2020 Oct; 6(10):5866-5873. PubMed ID: 33320575
[TBL] [Abstract][Full Text] [Related]
12. Modulation of NRF2/KEAP1 Signaling in Preeclampsia.
Tossetta G; Fantone S; Piani F; Crescimanno C; Ciavattini A; Giannubilo SR; Marzioni D
Cells; 2023 Jun; 12(11):. PubMed ID: 37296665
[TBL] [Abstract][Full Text] [Related]
13. Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia.
Iriyama T; Sun K; Parchim NF; Li J; Zhao C; Song A; Hart LA; Blackwell SC; Sibai BM; Chan LN; Chan TS; Hicks MJ; Blackburn MR; Kellems RE; Xia Y
Circulation; 2015 Feb; 131(8):730-41. PubMed ID: 25538227
[TBL] [Abstract][Full Text] [Related]
14. Placental oxidative DNA damage and its repair in preeclamptic women with fetal growth restriction.
Fujimaki A; Watanabe K; Mori T; Kimura C; Shinohara K; Wakatsuki A
Placenta; 2011 May; 32(5):367-72. PubMed ID: 21435716
[TBL] [Abstract][Full Text] [Related]
15. TLR9 (Toll-Like Receptor 9) Agonist Suppresses Angiogenesis by Differentially Regulating VEGFA (Vascular Endothelial Growth Factor A) and sFLT1 (Soluble Vascular Endothelial Growth Factor Receptor 1) in Preeclampsia.
He B; Yang X; Li Y; Huang D; Xu X; Yang W; Dai Y; Zhang H; Chen Z; Cheng W
Hypertension; 2018 Apr; 71(4):671-680. PubMed ID: 29437897
[TBL] [Abstract][Full Text] [Related]
16. Determinants of placental vascularity.
Torry DS; Hinrichs M; Torry RJ
Am J Reprod Immunol; 2004 Apr; 51(4):257-68. PubMed ID: 15212678
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia.
Matsubara K; Higaki T; Matsubara Y; Nawa A
Int J Mol Sci; 2015 Mar; 16(3):4600-14. PubMed ID: 25739077
[TBL] [Abstract][Full Text] [Related]
18. Targeted inhibition of complement activation prevents features of preeclampsia in mice.
Qing X; Redecha PB; Burmeister MA; Tomlinson S; D'Agati VD; Davisson RL; Salmon JE
Kidney Int; 2011 Feb; 79(3):331-9. PubMed ID: 20944547
[TBL] [Abstract][Full Text] [Related]
19. Preeclampsia: new insights.
Shah DM
Curr Opin Nephrol Hypertens; 2007 May; 16(3):213-20. PubMed ID: 17420664
[TBL] [Abstract][Full Text] [Related]
20. The severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restriction.
Kimura C; Watanabe K; Iwasaki A; Mori T; Matsushita H; Shinohara K; Wakatsuki A
J Matern Fetal Neonatal Med; 2013 Mar; 26(5):491-6. PubMed ID: 23035823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
